feed,title,long_url,short_url
Investors,A First-Ever In Ulcerative Colitis Sends Roivant Stock Into A Breakout,https://www.investors.com/news/technology/roiv-stock-hits-buy-point-on-a-first-ever-in-ulcerative-colitis-treatment/,https://da.gd/UdpEpi
